TriSalus Life Sciences, Inc. (TLSIW) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$18.01M | +55.9% |
| 2024 | -$40.84M | +19.2% |
| 2023 | -$50.58M | -56.5% |
| 2022 | -$32.31M | -1759.1% |
| 2021 | -$1.74M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$18.01M | +55.9% |
| 2024 | -$40.84M | +19.2% |
| 2023 | -$50.58M | -56.5% |
| 2022 | -$32.31M | -1759.1% |
| 2021 | -$1.74M | — |